Enhancing the Scientific Integrity and Safety of Clinical Trials: Recommendations for Data Monitoring Committees

Lewis et al talk about the risks of participating in a clinical trial which cannot be predicted with certainty at the time of trial design, especially when evaluating novel therapies. Accordingly, once the trial is initiated, periodic and ongoing review of accumulating study data is necessary to ensure the continued appropriateness of enrolling and treating patients in the trial.